729 related articles for article (PubMed ID: 25421826)
1. Treatment of severe lupus nephritis: the new horizon.
Chan TM
Nat Rev Nephrol; 2015 Jan; 11(1):46-61. PubMed ID: 25421826
[TBL] [Abstract][Full Text] [Related]
2. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
3. Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.
An Y; Zhou Y; Bi L; Liu B; Wang H; Lin J; Xu D; Wang M; Zhang J; Wang Y; An Y; Zhu P; Xie R; Zhang Z; Mei Y; Liu X; Deng X; Yao Z; Zhang Z; Wang Y; Xiao W; Shen H; Yang X; Xu H; Yu F; Wang G; Lu X; Li Y; Li Y; Zuo X; Li Y; Liu Y; Zhao Y; Guo J; Sun L; Zhao M; Li Z
Clin Rheumatol; 2019 Apr; 38(4):1047-1054. PubMed ID: 30488367
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for severe lupus nephritis.
Lenz O; Contreras G
Arch Immunol Ther Exp (Warsz); 2004; 52(5):356-65. PubMed ID: 15507877
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for lupus nephritis: an update.
Mok CC
Expert Rev Clin Immunol; 2015; 11(12):1353-64. PubMed ID: 26364748
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
Contreras G; Tozman E; Nahar N; Metz D
Lupus; 2005; 14 Suppl 1():s33-8. PubMed ID: 15803929
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
Navaneethan SD; Viswanathan G; Strippoli GF
Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
[TBL] [Abstract][Full Text] [Related]
8. Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.
Lenz O; Fornoni A; Contreras G
Drugs; 2005; 65(17):2429-36. PubMed ID: 16296869
[TBL] [Abstract][Full Text] [Related]
9. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
Zhang X; Ji L; Yang L; Tang X; Qin W
Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the treatment of proliferative lupus nephritis.
Chan TM
Am J Med; 2012 Jul; 125(7):642-8. PubMed ID: 22608789
[TBL] [Abstract][Full Text] [Related]
11. Treatment of lupus nephritis.
Shum K; Askanase A
Curr Rheumatol Rep; 2011 Aug; 13(4):283-90. PubMed ID: 21584691
[TBL] [Abstract][Full Text] [Related]
12. Update on the management of lupus nephritis: let the treatment fit the patient.
Bertsias G; Boumpas DT
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
[TBL] [Abstract][Full Text] [Related]
13. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?
Rovin BH; Parikh SV; Hebert LA; Chan TM; Mok CC; Ginzler EM; Hooi LS; Brunetta P; Maciuca R; Solomons N
Clin J Am Soc Nephrol; 2013 Jan; 8(1):147-53. PubMed ID: 22879439
[TBL] [Abstract][Full Text] [Related]
15. New treatment strategies for proliferative lupus nephritis: keep children in mind!
Ranchin B; Fargue S
Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
[TBL] [Abstract][Full Text] [Related]
16. Recent news in the treatment of lupus nephritis.
Tesar V; Hruskova Z
Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
[TBL] [Abstract][Full Text] [Related]
17. Current status of lupus nephritis.
Jaryal A; Vikrant S
Indian J Med Res; 2017 Feb; 145(2):167-178. PubMed ID: 28639592
[TBL] [Abstract][Full Text] [Related]
18. Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?
Lenz O; Waheed AA; Baig A; Pop A; Contreras G
Clin J Am Soc Nephrol; 2013 Jan; 8(1):162-71. PubMed ID: 22917704
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of tacrolimus for the treatment of moderate-to-severe lupus nephritis in China.
Kim S; Reen Ooi AY; Stephens T; Jiang H
J Comp Eff Res; 2019 Oct; 8(13):1125-1141. PubMed ID: 31580156
[No Abstract] [Full Text] [Related]
20. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
